The global spread of SARS-CoV-2/COVID-19 is devastating health systems and economies
worldwide. Recombinant or vaccine-induced neutralizing antibodies are used to combat the …

The global spread of SARS-CoV-2/COVID-19 is devastating health systems and economies
worldwide. Recombinant or vaccine-induced neutralizing antibodies are used to combat the …

The emergence of SARS-CoV-2 antigenic variants with increased transmissibility is a public
health threat. Some variants show substantial resistance to neutralization by SARS-CoV-2 …

SARS-CoV-2 and its variants continue to infect hundreds of thousands every day despite the
rollout of effective vaccines. Therefore, it is essential to understand the levels of protection …

The emergence of SARS-CoV-2 variants with mutations in the spike protein is raising
concerns about the efficacy of infection-or vaccine-induced antibodies to neutralize these …

Antibody responses against the SARS-CoV-2 Spike protein correlate with protection against
COVID-19. Serum neutralizing antibodies appear early after symptom onset following SARS …

Emerging SARS-CoV-2 variants of concern that overcome natural and vaccine-induced
immunity threaten to exacerbate the COVID-19 pandemic. Increasing evidence suggests …

Administration of convalescent plasma or neutralizing monoclonal antibodies (mAbs) is a
potent therapeutic option for coronavirus disease 2019 (COVID-19) caused by severe acute …

The continuous emergence of SARS-coronavirus 2 (SARS-CoV-2) variants, especially the
variants of concern (VOC), exacerbated the impact of the coronavirus disease 2019 (COVID …

Emerging SARS-CoV-2 variants raise questions about escape from previous immunity. As
the population immunity to SARS-CoV-2 has become more complex due to prior infections …